Compare Stocks: NVNO, TELA, BEAT, and PETV

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.49 +3.1%	$0.60	$0.47 ▼ $4.00	$26.95M	-0.78	465,987 shs	201,536 shs
NVNO enVVeno Medical	$10.29 -1.0%	$10.72	$8.67 ▼ $39.20	$7.09M	1.1	15,186 shs	21,197 shs
PETV PetVivo	$0.70	$0.75	$0.60 ▼ $1.69	$26.57M	1.27	10,759 shs	10,000 shs
TELA TELA Bio	$0.65 +1.1%	$0.76	$0.50 ▼ $2.00	$28.70M	1.34	171,262 shs	59,800 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	+3.14%	-1.20%	-11.39%	-43.85%	-55.96%
NVNO enVVeno Medical	-0.96%	-5.19%	-4.15%	-3.65%	-74.87%
PETV PetVivo	0.00%	+2.94%	+1.07%	-10.26%	-16.17%
TELA TELA Bio	+1.09%	+0.31%	-11.79%	-27.39%	-61.76%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.49 +3.1%	$0.60	$0.47 ▼ $4.00	$26.95M	-0.78	465,987 shs	201,536 shs
NVNO enVVeno Medical	$10.29 -1.0%	$10.72	$8.67 ▼ $39.20	$7.09M	1.1	15,186 shs	21,197 shs
PETV PetVivo	$0.70	$0.75	$0.60 ▼ $1.69	$26.57M	1.27	10,759 shs	10,000 shs
TELA TELA Bio	$0.65 +1.1%	$0.76	$0.50 ▼ $2.00	$28.70M	1.34	171,262 shs	59,800 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	+3.14%	-1.20%	-11.39%	-43.85%	-55.96%
NVNO enVVeno Medical	-0.96%	-5.19%	-4.15%	-3.65%	-74.87%
PETV PetVivo	0.00%	+2.94%	+1.07%	-10.26%	-16.17%
TELA TELA Bio	+1.09%	+0.31%	-11.79%	-27.39%	-61.76%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BEAT HeartBeam	2.67	Moderate Buy	$4.00	710.87% Upside
NVNO enVVeno Medical	2.33	Hold	N/A	N/A
PETV PetVivo	0.00	N/A	N/A	N/A
TELA TELA Bio	2.40	Hold	$2.20	240.40% Upside

Current Analyst Ratings Breakdown

Latest NVNO, TELA, BEAT, and PETV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/17/2026	TELA TELA Bio	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/14/2026	BEAT HeartBeam	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$2.00
7/7/2026	NVNO enVVeno Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
7/6/2026	NVNO enVVeno Medical	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/2/2026	BEAT HeartBeam	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/30/2026	NVNO enVVeno Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/15/2026	NVNO enVVeno Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
5/22/2026	BEAT HeartBeam	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$5.50 ➝ $2.50

(Data available from 8/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BEAT HeartBeam	N/A	N/A	N/A	N/A	$0.15 per share	N/A
NVNO enVVeno Medical	N/A	N/A	N/A	N/A	$30.28 per share	N/A
PETV PetVivo	$1.05M	25.40	N/A	N/A	($0.03) per share	-23.33
TELA TELA Bio	$80.28M	0.36	N/A	N/A	($0.35) per share	-1.85

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BEAT HeartBeam	-$21.01M	-$0.51	N/A	N/A	N/A	N/A	-686.78%	-348.65%	N/A
NVNO enVVeno Medical	-$19.47M	-$19.33	N/A	N/A	N/A	N/A	-62.28%	-56.83%	10/30/2026 (Estimated)
PETV PetVivo	-$10.95M	-$0.34	N/A	N/A	N/A	-902.82%	-4,813.07%	-281.78%	N/A
TELA TELA Bio	-$38.83M	-$0.77	N/A	N/A	N/A	-51.53%	-1,320.81%	-59.39%	N/A

Latest NVNO, TELA, BEAT, and PETV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	BEAT HeartBeam	-$0.0860	-$0.10	-$0.0140	-$0.10	$0.15 million	N/A
8/10/2026	Q2 2026	TELA TELA Bio	-$0.1738	-$0.20	-$0.0262	-$0.20	$20.01 million	$19.29 million
7/30/2026	Q2 2026	NVNO enVVeno Medical	-$4.69	-$5.37	-$0.68	-$5.37	$1.00 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BEAT HeartBeam	N/A	N/A	N/A	N/A	N/A
NVNO enVVeno Medical	N/A	N/A	N/A	N/A	N/A
PETV PetVivo	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BEAT HeartBeam	N/A	3.66	3.61
NVNO enVVeno Medical	N/A	11.70	11.70
PETV PetVivo	0.02	0.42	0.47
TELA TELA Bio	8.82	2.99	2.38

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BEAT HeartBeam	7.77%
NVNO enVVeno Medical	34.71%
PETV PetVivo	24.55%
TELA TELA Bio	94.35%

Insider Ownership

Company	Insider Ownership
BEAT HeartBeam	17.95%
NVNO enVVeno Medical	15.00%
PETV PetVivo	10.84%
TELA TELA Bio	5.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BEAT HeartBeam	1,700	56.35 million	46.23 million	Not Optionable
NVNO enVVeno Medical	30	680,000	581,000	Optionable
PETV PetVivo	20	37.95 million	19.06 million	Not Optionable
TELA TELA Bio	120	44.90 million	42.61 million	Optionable

NVNO, TELA, BEAT, and PETV Headlines

Recent News About These Companies

TELA Bio (TELA) Q2 2026 Earnings Call Transcript

August 19 at 5:35 PM | finance.yahoo.com

Heather Getz Acquires 15,000 Shares of TELA Bio (NASDAQ:TELA) Stock

August 18, 2026 | insidertrades.com

Tela Bio outlines 9- to 12-month sales ramp while withdrawing full-year revenue guidance

August 12, 2026 | seekingalpha.com

TELA Bio Q2 Earnings Call Highlights

August 12, 2026 | americanbankingnews.com

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

August 10, 2026 | zacks.com

TELA Bio Reports Second Quarter 2026 Financial Results

August 10, 2026 | markets.businessinsider.com

Tela Bio names new CEO as Malvern medtech company eyes next growth phase

August 5, 2026 | msn.com

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 5, 2026 | globenewswire.com

Tela Bio names new CEO as co-founder exits after 14 years

August 4, 2026 | bizjournals.com

TELA Bio Appoints Heather Getz as Chief Executive Officer and Director

August 4, 2026 | quiverquant.comQ

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

August 4, 2026 | globenewswire.com

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 29, 2026 | globenewswire.com

TELA Bio to Announce Second Quarter 2026 Financial Results

July 20, 2026 | globenewswire.com

A perfect match

July 16, 2026 | bbc.comB

TELA Bio Healthcare Story Faces New Market Scrutiny

May 15, 2026 | kalkinemedia.comK

Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25

May 15, 2026 | finance.yahoo.com

TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...

May 13, 2026 | finance.yahoo.com

TELA Bio, Inc. (TELA) Q1 2026 Earnings Call Transcript

May 12, 2026 | seekingalpha.com

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

May 12, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NVNO, TELA, BEAT, and PETV Company Descriptions

HeartBeam NASDAQ:BEAT

$0.49 +0.02 (+3.14%)

As of 08/21/2026 04:00 PM Eastern

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

enVVeno Medical NASDAQ:NVNO

$10.29 -0.10 (-0.96%)

As of 08/21/2026 03:34 PM Eastern

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

PetVivo NASDAQ:PETV

$0.70 0.00 (0.00%)

As of 08/20/2026 11:11 AM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

TELA Bio NASDAQ:TELA

$0.65 +0.01 (+1.09%)

As of 08/21/2026 04:00 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NVNO, TELA, BEAT, and PETV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NVNO, TELA, BEAT, and PETV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NVNO, TELA, BEAT, and PETV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NVNO, TELA, BEAT, and PETV Company Descriptions

HeartBeam NASDAQ:BEAT

enVVeno Medical NASDAQ:NVNO

PetVivo NASDAQ:PETV

TELA Bio NASDAQ:TELA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NVNO, TELA, BEAT, and PETV Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NVNO, TELA, BEAT, and PETV Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NVNO, TELA, BEAT, and PETV Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NVNO, TELA, BEAT, and PETV Company Descriptions

HeartBeam NASDAQ:BEAT

enVVeno Medical NASDAQ:NVNO

PetVivo NASDAQ:PETV

TELA Bio NASDAQ:TELA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools